Risk factors and predictors of compliance in depression

[1]  Mark Olfson,et al.  Interventions to improve medication adherence in schizophrenia. , 2002, The American journal of psychiatry.

[2]  Gill Livingston,et al.  ‘Just keep taking the tablets’: adherence to antidepressant treatment in older people in primary care , 2002, International journal of geriatric psychiatry.

[3]  C. Nemeroff,et al.  Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. , 2002, The Journal of clinical psychiatry.

[4]  A. Vergouwen,et al.  Patient adherence with antidepressant treatment. , 2002, The British journal of psychiatry : the journal of mental science.

[5]  B. Kupelnick,et al.  Patient adherence in the treatment of depression , 2002, British Journal of Psychiatry.

[6]  R. Hays,et al.  Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. , 2001, JAMA.

[7]  G. Alexopoulos,et al.  Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. , 2001, Psychiatric services.

[8]  W. Katon,et al.  Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. , 2001, The American journal of psychiatry.

[9]  N. Duan,et al.  Two-year effects of quality improvement programs on medication management for depression. , 2001, Archives of general psychiatry.

[10]  K. Demyttenaere,et al.  Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. , 2001, Journal of affective disorders.

[11]  K. Demyttenaere,et al.  Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment. , 2001, The Journal of clinical psychiatry.

[12]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[13]  W. Katon,et al.  Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. , 1999, Archives of general psychiatry.

[14]  Michael J. Campbell,et al.  Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial , 1999, BMJ.

[15]  R. Rosenheck,et al.  Compliance with medication regimens for mental and physical disorders. , 1998, Psychiatric services.

[16]  F. Leenen,et al.  Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. , 1997, The Canadian journal of cardiology.

[17]  K. Demyttenaere.  Compliance during treatment with antidepressants. , 1997, Journal of affective disorders.

[18]  J. Kleijnen,et al.  Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness , 1996, BMJ.

[19]  B. Blackwell.  From compliance to alliance. A quarter century of research. , 1996, The Netherlands journal of medicine.

[20]  W. Katon,et al.  Collaborative management to achieve treatment guidelines. Impact on depression in primary care. , 1995, JAMA.

[21]  J. Cramer,et al.  Optimizing long-term patient compliance. , 1995, Neurology.

[22]  W. Katon,et al.  The Role of the Primary Care Physician in Patients' Adherence to Antidepressant Therapy , 1995, Medical care.

[23]  J. Brun.  Patient Compliance with Once-Daily and Twice-daily Oral Formulations of 5-Isosorbide Mononitrate: A Comparative Study , 1994, The Journal of international medical research.

[24]  C. Thompson,et al.  The compliance with antidepressants in general practice , 1994, Journal of psychopharmacology.

[25]  E H Wagner,et al.  Patterns of antidepressant use in community practice. , 1993, General hospital psychiatry.

[26]  J. Greden.  Antidepressant maintenance medications: when to discontinue and how to stop. , 1993, The Journal of clinical psychiatry.

[27]  S. Weddington,et al.  A Question of Choice , 1993 .

[28]  Joyce A. Cramer,et al.  Patient Compliance in Medical Practice and Clinical Trials , 1991 .

[29]  D. Kupfer,et al.  Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.

[30]  N. Col,et al.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.

[31]  J. Cramer,et al.  How often is medication taken as prescribed? A novel assessment technique. , 1989, JAMA.

[32]  B. Bloom,et al.  NSAID dosing schedule and compliance , 1988, Drug intelligence & clinical pharmacy.

[33]  G. Bartkó,et al.  Clinical symptomatology and drug compliance in schizophrenic patients , 1988, Acta psychiatrica Scandinavica.

[34]  J. Kane.  Prevention and Treatment of Neuroleptic Noncompliance , 1986 .

[35]  L. W. Buckalew,et al.  An Investigation of Drug Expectancy as a Function of Capsule Color and Size and Preparation Form , 1982, Journal of clinical psychopharmacology.

[36]  R. Brian Haynes,et al.  Compliance in Health Care , 1979 .

[37]  K. Demyttenaere,et al.  Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. , 2001, The Journal of clinical psychiatry.

[38]  R. Judge,et al.  Patient perspectives on once-weekly fluoxetine. , 2001, The Journal of clinical psychiatry.

[39]  F. Schneier.  Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder. , 2001 .

[40]  R. Rosenheck,et al.  Enhancing medication compliance for people with serious mental illness. , 1999, The Journal of nervous and mental disease.

[41]  J. Cramer.  Enhancing Patient Compliance in the Elderly , 1998, Drugs & aging.

[42]  L. W. Buckalew,et al.  Patient compliance and medication perception. , 1986, Journal of clinical psychology.